openPR Logo
Press release

Obesity Market to Witness Growth by 2032 | Major players- Novo Nordisk, Eli Lilly and Company, MedImmune, Boehringer Ingelheim, Raziel Therapeutics, Altimmune, Saniona, YSOPIA Bioscience, Innovent Biologics, Glaceum, Shionogi, Aardvark Therapeutics, NuSir

01-24-2024 04:46 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Obesity Market

Obesity Market

DelveInsight's "Obesity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Obesity, historical and forecasted epidemiology as well as the Obesity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Obesity market report provides current treatment practices, emerging drugs, Obesity market share of the individual therapies, and current and forecasted Obesity market size from 2019 to 2032 segmented by seven major markets. The Report also covers current Obesity treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Obesity market.

Request for a Free Sample Report @ https://www.delveinsight.com/sample-request/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Obesity Overview

Obesity is a medical condition characterized by the accumulation of excess body fat to the extent that it may have adverse effects on health. It is often determined by the body mass index (BMI), which is a measure of weight in relation to height. Generally, a BMI of 30 or higher is considered indicative of obesity.

Causes of Obesity:

Dietary Habits: Consuming excessive calories, especially from high-fat and high-sugar foods, can contribute to weight gain.

Lack of Physical Activity: Sedentary lifestyles with little or no physical activity can lead to weight gain and obesity.

Genetics: Genetic factors can influence an individual's susceptibility to obesity.

Environmental Factors: Environmental factors, such as access to unhealthy food options and sedentary work environments, can contribute to obesity.

Psychological Factors: Emotional factors, stress, and certain mental health conditions can contribute to unhealthy eating habits and weight gain.

Health Consequences of Obesity:

Obesity is associated with a range of health issues, including:

Cardiovascular Diseases: Increased risk of heart disease, stroke, and high blood pressure.

Type 2 Diabetes: Obesity is a major risk factor for the development of type 2 diabetes.

Respiratory Issues: Obesity can lead to respiratory problems, including sleep apnea and asthma.

Joint Problems: Excess weight puts strain on joints, leading to conditions like osteoarthritis.

Cancers: Obesity is linked to an increased risk of certain cancers, including breast, colorectal, and endometrial cancer.

Liver Disease: Non-alcoholic fatty liver disease (NAFLD) is more common in obese individuals.

Psychological Impact: Obesity can contribute to mental health issues such as depression and low self-esteem.

Prevention and Management:

Healthy Diet: Adopting a balanced and nutritious diet with appropriate portion control is crucial for weight management.

Regular Physical Activity: Engaging in regular physical activity helps burn calories and maintain overall health.

Behavioral Changes: Addressing unhealthy eating habits and promoting positive lifestyle changes.

Medical Intervention: In some cases, medical interventions such as medications or surgery may be considered under the guidance of healthcare professionals.

Support and Counseling: Support from healthcare providers, dietitians, and mental health professionals can be beneficial for those struggling with obesity.

Community Programs: Community-based initiatives promoting healthy eating and active living can contribute to obesity prevention.

It's important to approach weight management holistically, considering both physical and mental well-being. Individuals concerned about obesity should consult with healthcare professionals for personalized advice and guidance.

Visit to know more about the Obesity, treatment algorithms in different geographies, and patient journey contact to receive a sample @ https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Obesity Market

The Obesity market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Obesity market trends by analyzing the impact of current Obesity therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.

This segment gives a thorough detail of the Obesity market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Obesity market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Obesity market in 7MM is expected to witness a major change in the study period 2019-2032.

Request a sample and discover more about the report offerings at:
https://www.delveinsight.com/sample-request/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Obesity Epidemiology

The Obesity epidemiology section provides insights into the historical and current Obesity patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Obesity market report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Explore more about the Obesity Epidemiology at: https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Obesity Drugs Uptake

This section focuses on the rate of uptake of the potential Obesity drugs recently launched in the Obesity market or expected to get launched in the market during the study period 2019-2032. The analysis covers the Obesity market uptake by drugs; patient uptake by therapies; and sales of each drug.

Obesity Drugs Uptake helps in understanding the drugs with the most rapid uptake, and the reasons behind the maximal use of new drugs, and allows the comparison of the drugs on the basis of Obesity market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Obesity Pipeline Development Activities

The Obesity report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Obesity key players involved in developing targeted therapeutics.

Request for a sample report to understand more about the Obesity pipeline development activities at: https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Obesity Therapeutics Assessment

Major key companies such as Novo Nordisk, Eli Lilly and Company, MedImmune, Boehringer Ingelheim, Raziel Therapeutics, Altimmune, Saniona, YSOPIA Bioscience, Innovent Biologics, Glaceum, Shionogi, Aardvark Therapeutics, NuSirt Biopharma, Novartis, CSPC Baike (Shandong) Biopharmaceutical, Jiangsu HengRui Medicine, Carmot Therapeutics, Pfizer, Sciwind Biosciences, Empros Pharma, and others are working proactively in the Obesity therapeutics market to develop novel therapies which will drive the Obesity treatment market in the upcoming years.

Learn more about the emerging therapies & key companies at: https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Obesity Report Key Insights

1. Obesity Patient Population
2. Obesity Market Size and Trends
3. Key Cross Competition in the Obesity Market
4. Obesity Market Dynamics (Key Drivers and Barriers)
5. Obesity Market Opportunities
6. Obesity Therapeutic Approaches
7. Obesity Pipeline Analysis
8. Obesity Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Obesity Market

Table of Contents

1. Key Insights
2. Executive Summary
3. Obesity Competitive Intelligence Analysis
4. Obesity Market Overview at a Glance
5. Obesity Disease Background and Overview
6. Obesity Patient Journey
7. Obesity Epidemiology and Patient Population
8. Obesity Treatment Algorithm, Current Treatment, and Medical Practices
9. Obesity Unmet Needs
10. Key Endpoints of Obesity Treatment
11. Obesity Marketed Products
12. Obesity Emerging Therapies
13. Obesity Seven Major Market Analysis
14. Attribute Analysis
15. Obesity Market Outlook (7 major markets)
16. Obesity Access and Reimbursement Overview
17. KOL Views on the Obesity Market
18. Obesity Market Drivers
19. Obesity Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

Get the Detailed TOC of the Obesity Market report here: https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Contact Us:

Kritika Rehani
info@delveinsight.com
+91-9650213330
www.delveinsight.com

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Obesity Market to Witness Growth by 2032 | Major players- Novo Nordisk, Eli Lilly and Company, MedImmune, Boehringer Ingelheim, Raziel Therapeutics, Altimmune, Saniona, YSOPIA Bioscience, Innovent Biologics, Glaceum, Shionogi, Aardvark Therapeutics, NuSir here

News-ID: 3362055 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Obesity

Anti-Obesity Drugs Market Grows Rapidly, Driven by Obesity Rates and Therapeutic …
Anti-Obesity Drugs Market valued at USD 5.9 Bn in 2024, growing at 16.5% CAGR to reach USD 20.02 Bn by 2032. Driven by GLP-1 therapies and rising obesity rates. Anti Obesity Drugs Market Overview: The anti-obesity drugs market is undergoing significant transformation as awareness about obesity-related health risks rises globally. With growing concern over lifestyle-related disorders, there is an increasing emphasis on medical intervention as a complement to traditional weight management strategies.
03-18-2025 | Health & Medicine
Getnews
Fuzzle joins The Obesity Society & The Obesity Action Coalition; Promotes Habit- …
Building healthy, sustainable habits for long-term weight management success. Tampa, FL - March 18, 2025 - Fuzzle, an emerging leader in the wellness landscape, is pleased to announce that it's now a Member of The Obesity Society, as well as the Obesity Action Coalition, marking a new milestone in the company's mission to transform how individuals approach weight loss. Image: https://www.globalnewslines.com/uploads/2025/03/77da787ae98a633847c70fc22e2943c7.jpg Fuzzle supports individuals in their wellness journey through non-invasive, drug-free strategies. With
Pediatric Obesity Management Market - Healthy Habits for Life: Advancing Pediatr …
Newark, New Castle, USA: The "Pediatric Obesity Management Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Pediatric Obesity Management Market: https://www.growthplusreports.com/report/pediatric-obesity-management-market/8930 This latest report researches the industry structure,
Anti-Obesity Drugs Market - From Obesity to Vitality: Leading the Way in Effecti …
Newark, New Castle, USA - new report, titled Anti-Obesity Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Anti-Obesity Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Anti-Obesity Drugs market. The report offers an overview of the market, which
Increasing Prevalence of Obesity Driving Obesity/Bariatric Surgery Devices Marke …
The global obesity/bariatric surgery devices market revenue stood at $1.4 billion in 2016, and it is expected to rise to $2.8 billion by 2023. Furthermore, the market will progress at a CAGR of 9.9% from 2017 to 2023 (forecast period), as per the estimates of the market research company, P&S Intelligence. The major growth drivers of the market are the rising incidence of obesity, owing to unhealthy diets and lifestyle
Fast Food and Obesity
Most of the fast food in the market contains a large quantity of sugar, #carbs and fats with a lesser quantity of vitamins and minerals. The unhealthy food ingredients in the fast food are further increased with increased portion size. The person will still consume the whole meal regardless of being completely full. People cannot stop ravishing on fast food because it is available for low cost and in close